Zimmer Biomet Holdings Inc (ZBH)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 1,024,000 474,300 505,600 449,700 231,400 277,900 229,500 217,700 401,600 819,300 916,200 567,700 -138,900 -151,900 36,700 377,000 1,131,600 -90,200 -359,100 -307,800
Total assets US$ in thousands 21,496,900 21,217,300 21,294,300 21,243,500 21,066,000 21,333,300 21,452,700 21,617,500 23,456,400 24,008,600 24,223,200 24,026,600 24,417,700 24,025,500 23,647,600 25,512,900 24,638,700 24,315,200 24,205,700 24,289,000
ROA 4.76% 2.24% 2.37% 2.12% 1.10% 1.30% 1.07% 1.01% 1.71% 3.41% 3.78% 2.36% -0.57% -0.63% 0.16% 1.48% 4.59% -0.37% -1.48% -1.27%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $1,024,000K ÷ $21,496,900K
= 4.76%

Zimmer Biomet Holdings Inc's return on assets (ROA) has shown variability over the past eight quarters. The ROA ranged from a low of 1.01% in Q1 2022 to a high of 4.76% in Q4 2023. This indicates fluctuations in the company's ability to generate profits relative to its total assets during the period under review. Overall, there seems to be an improving trend in ROA from the earlier quarters of 2022 to the later quarters of 2023, suggesting potential efficiency gains in asset utilization or profitability improvement. Further analysis would be required to determine the underlying factors contributing to these changes in ROA and their implications for the company's financial performance and operational effectiveness.


Peer comparison

Dec 31, 2023